VeriMomБезопасен ли kigelia africana leaf extract при беременности?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment identified for kigelia africana leaf extract. Peer‑reviewed literature reports pharmacological and topical activities (antioxidant, antimicrobial, anti‑inflammatory) but no animal or human reproductive toxicity or teratogenicity data were found, therefore no evidence of reproductive hazard; topical use would be expected to give low but measurable dermal exposure in adults (low systemic absorption typical for botanical extracts) (sources: PubMed, PubChem, ECHA C&L, CosIng).
Related ingredients
Frequently asked questions
- Безопасен ли kigelia africana leaf extract при беременности?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment identified for kigelia africana leaf extract. Peer‑reviewed literature reports pharmacological and topical activities (antioxidant, antimicrobial, anti‑inflammatory) but no animal or human reproductive toxicity or teratogenicity data were found, therefore no evidence of reproductive hazard; topical use would be expected to give low but measurable dermal exposure in adults (low systemic absorption typical for botanical extracts) (sources: PubMed, PubChem, ECHA C&L, CosIng).
- Безопасен ли kigelia africana leaf extract при грудном вскармливании?
- No data indicating reproductive or lactation toxicity or breastmilk transfer. In absence of evidence for systemic reproductive toxicity, hazard and mechanism are scored 0; low but measurable systemic exposure from topical use is plausible, so exposure scored as low (adult topical exposure) (sources: PubMed, PubChem, ECHA C&L, CosIng).
- Безопасен ли kigelia africana leaf extract для кожи малыша?
- No infant‑specific safety or developmental toxicity data were identified. Hazard and mechanism remain 0 due to lack of evidence for reproductive/endocrine effects. Exposure for baby skin is increased relative to adults because of thinner/immature barrier and higher surface‑area‑to‑weight; therefore exposure is elevated to moderate for 0–3 yr (adult low exposure +1) (sources: PubMed, PubChem, CosIng, ECHA C&L).
- Как VeriMom оценивает kigelia africana leaf extract?
- VeriMom оценивает kigelia africana leaf extract в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы kigelia africana leaf extract при беременности?
- См. наш список безопасных альтернатив kigelia africana leaf extract с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.